Laura Calabresi Selected Research

Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)

1/2021	High-Density Lipoproteins and the Kidney.
7/2020	Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease.
1/2019	A proteomic approach to identify novel disease biomarkers in LCAT deficiency.
1/2019	Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
1/2017	Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
6/2016	High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis.
1/2016	Lipoprotein X Causes Renal Disease in LCAT Deficiency.
1/2012	Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma.
7/2011	[LCAT deficiency: a nephrological diagnosis].
8/2009	Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Calabresi Research Topics

Disease

21	Atherosclerosis 03/2021 - 09/2002
19	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2022 - 06/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2003
10	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2008
8	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 11/2013 - 02/2002
5	Hypercholesterolemia 01/2021 - 09/2005
5	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 11/2017
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2014
4	Acute Coronary Syndrome 01/2019 - 10/2003
4	Coronary Disease (Coronary Heart Disease) 06/2016 - 06/2002
4	Amyloidosis 01/2015 - 05/2004
4	Ischemia 02/2008 - 02/2003
4	Reperfusion Injury 09/2006 - 02/2003
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Myocardial Infarction 01/2021 - 02/2013
3	Essential Thrombocythemia 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 11/2017
3	Anemia 05/2020 - 07/2011
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2019 - 01/2018
3	ST Elevation Myocardial Infarction 01/2019 - 01/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016 - 04/2003
3	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015 - 05/2004
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 05/2008 - 02/2004
3	Heart Neoplasms 02/2008 - 02/2003
3	Necrosis 02/2008 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 03/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2019
2	Homozygous Familial Hypercholesterolemia 01/2021 - 01/2017
2	Chronic Renal Insufficiency 01/2021 - 07/2020
2	Non-alcoholic Fatty Liver Disease 12/2020 - 12/2019
2	Inflammation (Inflammations) 11/2017 - 10/2017
2	Hypertriglyceridemia 11/2015 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 03/2004
2	Corneal Opacity 12/2012 - 07/2011
2	Cholesteryl Ester Transfer Protein Deficiency 07/2012 - 02/2002
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 05/2012 - 02/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 01/2004
1	Abdominal Obesity 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Gliosis 12/2021
1	Albuminuria 01/2021
1	Infarction (Infarctions) 01/2021
1	Polycythemia Vera 01/2021
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 05/2020
1	Cytopenia 05/2020
1	Splenomegaly 05/2020

Drug/Important Bio-Agent (IBA)

30	CholesterolIBA 01/2022 - 02/2002
23	LipidsIBA 01/2022 - 02/2003
22	HDL LipoproteinsIBA 01/2021 - 02/2003
19	HDL CholesterolIBA 01/2021 - 03/2006
15	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 02/2003
14	Lipoproteins (Lipoprotein)IBA 01/2022 - 02/2004
12	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 01/2021 - 06/2004
12	oxidized low density lipoproteinIBA 01/2021 - 04/2003
9	EnzymesIBA 01/2020 - 05/2006
8	ApolipoproteinsIBA 01/2021 - 09/2002
7	LDL CholesterolIBA 01/2020 - 08/2006
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2005
4	Apolipoproteins B (ApoB)IBA 01/2022 - 05/2012
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2005
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2009
4	Pharmaceutical PreparationsIBA 05/2020 - 03/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 10/2015
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2013
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017 - 05/2004
3	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2015 - 09/2013
3	Fenofibrate (CiL)FDA LinkGeneric 11/2015 - 06/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 02/2005
3	Creatine Kinase (Creatine Phosphokinase)IBA 02/2008 - 02/2003
2	CER-001IBA 01/2022 - 01/2021
2	Cholesterol Ester Transfer ProteinsIBA 03/2021 - 07/2012
2	red yeast riceIBA 01/2021 - 01/2014
2	CalreticulinIBA 01/2021 - 01/2019
2	BMS201038IBA 01/2021 - 01/2017
2	CytokinesIBA 01/2020 - 01/2016
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 05/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 03/2006
2	Cell Adhesion MoleculesIBA 01/2017 - 11/2007
2	Nonsense Codon (Nonsense Mutation)IBA 07/2012 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 06/2011 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 02/2003
2	apolipoprotein A-I MilanoIBA 11/2007 - 02/2007
2	Apoprotein(a) (Apolipoprotein (a))IBA 09/2006 - 03/2006
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2004 - 02/2003
1	Sterol O-Acyltransferase 2IBA 01/2022
1	OxysterolsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	LigandsIBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Erythropoietin FDA Link 01/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 02/2003
2	Blood Component Removal (Apheresis) 01/2021 - 01/2017
2	Injections 09/2006 - 03/2006
1	Splenectomy 05/2020